Article
Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events.
American heart journal - 1 Sept 2010
Tiroch Klaus A, Sibbing Dirk, Koch Werner, Roosen-Runge Tobias, Mehilli Julinda, Schömig Albert, Kastrati Adnan
Abstract excerpt
BACKGROUND: The prodrug clopidogrel requires activation by cytochrome P-450 (CYP) enzymes for its antiplatelet effect. The genes encoding enzymes for clopidogrel activation are polymorphic, leading to reduced or increased function, depending on the respective genotype. Reduced-function alleles have been associated with an increase in cardiovascular events. METHODS: We tested the association of the presence of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
